Form 483

Cape Cod Hospital Form 483, 2019-02-15

FDA issued a Form 483 to Cape Cod Hospital on 2019-02-15 with 5 public-safe observations.

483· Form 483 issuedBiologics5 observations

Cape Cod Hospital · Hyannis, United States · Issued February 15, 2019

Overview

  • 5 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

15 Feb 2019
21 CFR 211.110(b)

In-process conformity - examination, sample testing

Cited by Elizabeth B Griffin

15 Feb 2019
21 CFR 606.100(b)

Establish, maintain and follow manufacturing SOPs

Cited by Elizabeth B Griffin

15 Feb 2019
21 CFR 606.160(e)(1)

Donor deferral record - each location

Cited by Elizabeth B Griffin

15 Feb 2019
21 CFR 610.41

Donor Deferral

Cited by Elizabeth B Griffin

15 Feb 2019
21 CFR 630.10(f)(6)(ii)

Physical Assessment Determination - Skin Examination

Cited by Elizabeth B Griffin

Inspected site

CCCape Cod HospitalHyannis, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.110(b)Cited across public-safe Form 483 observations1x
21 CFR 606.100(b)Cited across public-safe Form 483 observations1x
21 CFR 606.160(e)(1)Cited across public-safe Form 483 observations1x
21 CFR 610.41Cited across public-safe Form 483 observations1x
21 CFR 630.10(f)(6)(ii)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 5 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere